Ikarian Capital, LLC Madrigal Pharmaceuticals, Inc. Put Options Transaction History

Ikarian Capital, LLC

  • $573 Million
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$212.22 - $292.96 $4.99 Million - $6.88 Million
23,500 New
23,500 $4.99 Million
Q1 2024

May 15, 2024
BUY
$171.37 - $283.23 $8.81 Million - $14.6 Million
51,400 New
51,400 $13.7 Million
Q4 2022

Feb 14, 2023
BUY
$58.39 - $296.54 $17.5 Million - $89 Million
300,000 New
300,000 $87.1 Million
Q4 2019

Jan 31, 2020
BUY
$84.28 - $118.5 $8.43 Million - $11.9 Million
100,000 New
100,000 $9.11 Million

Others Institutions Holding MDGL

# of Institutions
297
Shares Held
22M
Call Options Held
819K
Put Options Held
640K
View Full List

About MADRIGAL PHARMACEUTICALS, INC.

MDGL Quotes by TradingView
  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.28B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email